Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
$1.01
-1.0%
$0.95
$0.80
$1.70
$28.12M0.88,275 shs1,749 shs
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$0.01
+900.0%
$0.00
$0.00
$0.07
$426K-0.0611,313 shs1,222 shs
MMTec, Inc. stock logo
MTC
MMTec
$0.93
+1.1%
$0.96
$0.76
$6.42
$23.63M0.3170,033 shs28,314 shs
Semantix, Inc. stock logo
STIX
Semantix
$0.00
$0.28
$4.77
$23.73M-0.3752,087 shsN/A
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
0.00%+8.84%+4.23%+2.12%+12.22%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
0.00%0.00%+9,900.00%+4,900.00%+9,900.00%
MMTec, Inc. stock logo
MTC
MMTec
0.00%-6.65%-3.76%-9.27%-59.64%
Semantix, Inc. stock logo
STIX
Semantix
0.00%0.00%0.00%0.00%-99.56%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
N/AN/AN/AN/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
N/AN/AN/AN/AN/AN/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
0.00
N/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
0.00
N/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
0.00
N/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
$142.81M0.20N/AN/A$2.50 per share0.40
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
$1.10M0.39N/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
$1.87M12.53N/AN/A$1.07 per share0.87
Semantix, Inc. stock logo
STIX
Semantix
$264.23M0.00N/AN/A$1.01 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
-$2.33MN/A0.00N/AN/AN/AN/A10/16/2025 (Estimated)
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/A-$2.24N/AN/AN/AN/AN/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
-$91.17MN/A0.00N/AN/AN/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
-$63.61M-$0.81N/AN/AN/A-69.49%-45.45%-26.98%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
N/AN/AN/AN/AN/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
N/AN/AN/AN/AN/A
Semantix, Inc. stock logo
STIX
Semantix
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
N/A
1.74
N/A
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
N/AN/AN/A
MMTec, Inc. stock logo
MTC
MMTec
1.20
0.41
0.41
Semantix, Inc. stock logo
STIX
Semantix
N/A
1.61
1.61

Institutional Ownership

CompanyInstitutional Ownership
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
0.24%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
81.56%
MMTec, Inc. stock logo
MTC
MMTec
0.25%
Semantix, Inc. stock logo
STIX
Semantix
40.12%

Insider Ownership

CompanyInsider Ownership
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
58.72%
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
9.00%
MMTec, Inc. stock logo
MTC
MMTec
12.80%
Semantix, Inc. stock logo
STIX
Semantix
35.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
CLPS Incorporation stock logo
CLPS
CLPS Incorporation
3,32527.84 million11.49 millionOptionable
Kaleido Biosciences, Inc. stock logo
KLDO
Kaleido Biosciences
8042.62 million38.79 millionNot Optionable
MMTec, Inc. stock logo
MTC
MMTec
6025.19 million21.96 millionNot Optionable
Semantix, Inc. stock logo
STIX
Semantix
479.10 million51.02 millionNot Optionable

Recent News About These Companies

Semantix, Inc. (STIXF)
Semantix Announces CFO Resignation and Succession Plan
Semantix Inc Class A
Semantix Inc Class A STIX
Semantix, Inc.: Semantix Announces 3Q 2023 Financial Results
Semantix Announces 3Q 2023 Financial Results
Earnings Preview For Semantix
What's in the Cards for Semantix, Inc.'s (STIX) Q3 Earnings?
Pick Up Stix at Excalibur

Media Sentiment Over Time

CLPS Incorporation stock logo

CLPS Incorporation NASDAQ:CLPS

$1.01 -0.01 (-0.98%)
Closing price 08/22/2025 03:59 PM Eastern
Extended Trading
$1.00 -0.01 (-0.50%)
As of 08/22/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLPS Incorporation provides information technology (IT), consulting, and solutions to institutions operating in banking, insurance, and financial sectors in the People's Republic of China and internationally. It offers IT consulting services in credit card business areas, such as credit card application, account setup, authorization and activation, settlement, collection, promotion, point system, anti-fraud, statement, reporting, and risk management. The company also provides banking services, including business analysis, system design, development, testing, system maintenance, and operation support; and services in loans, deposit, general ledger, wealth management, debit card, anti-money-laundering, statement and reporting, and risk management, as well as architecture consulting services for banking systems, and online and mobile banking. In addition, it offers solutions in the field of wealth management; e-commerce solutions in online platforms, cross-border e-commerce, logistics, and back-end technology, such as big data analysis and intelligent decision-making; and driving, automatic control, and other AI-driven technology solutions for the automotive industry. Further, the company provides IT services to its clients in the banking, wealth management, e-commerce, and automotive industries; and software project development, maintenance, and testing services. Additionally, it offers CLPS Virtual Banking platform, a training platform for IT talents; recruitment and headhunting; and fee-for-service training services, as well as sells product and third-party software. The company was founded in 2005 and is headquartered in Kwun Tong, Hong Kong.

Kaleido Biosciences stock logo

Kaleido Biosciences NASDAQ:KLDO

$0.01 +0.01 (+900.00%)
As of 08/22/2025 11:01 AM Eastern

Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

MMTec stock logo

MMTec NASDAQ:MTC

$0.93 +0.01 (+1.09%)
Closing price 08/22/2025 03:58 PM Eastern
Extended Trading
$0.91 -0.02 (-2.15%)
As of 08/22/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MMTec, Inc., together with its subsidiaries, develops and deploys platforms that enable financial institutions to engage in securities market transactions and settlements worldwide. The company operates in two segments, Gujia and MM Global. It offers Internet-based securities solutions comprising Securities Dealers Trading System, which supports securities registration and clearing, account management, risk management, trading and execution, and third party access middleware; Private Fund Investment Management System that supports multi-account management, fund valuation, risk management, quantitative trading access, liquidation, and requisition management; and Mobile Transaction Individual Client System and PC Client System for Apple IOS, Android, PC, and Web applications. The company enables its customers to white label its trading interface, as well as select modular functionalities. It serves hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms. MMTec, Inc. was incorporated in 2018 and is headquartered in Sheung Wan, Hong Kong.

Semantix stock logo

Semantix NASDAQ:STIX

Semantix, Inc., together with its subsidiaries, provides end-to-end proprietary Software as a Service (SaaS) data platform in Latin America and the United States. The company offers SDP, a multi-cloud SaaS data platform that provides data integration, data operations, machine learning operations, data governance, data sharing, and data visualization for financial institutions; healthcare plans operators, health insurance brokers, hospitals, clinics, and imaging and diagnostics facilities; and retailers. It also sells third-party software licenses to the finance, retail, telecommunications, healthcare, industrials, and other sectors. In addition, the company offers artificial intelligence and data analytics services, including consulting, cloud monitoring, data integration, data science, and data engineering. The company was founded in 2010 and is based in São Paulo, Brazil.